What is Ravicti, and what condition does it treat?
Ravicti (glycerol phenylbutyrate) is a prescription medicine used to treat hyperammonemia (high ammonia levels) in people with urea cycle disorders (UCDs). [1]
How does Ravicti work?
Ravicti works by helping the body dispose of excess nitrogen. It is converted into compounds that bind nitrogen and allow it to be eliminated from the body, helping lower ammonia levels. [1]
How is Ravicti taken (formulation and dosing basics)?
Ravicti is taken by mouth. It is formulated as an oral liquid, and dosing is individualized based on a person’s condition and response. [1]
What are common side effects patients report or clinicians monitor?
Commonly reported side effects for Ravicti can include gastrointestinal effects such as nausea, vomiting, diarrhea, and abdominal discomfort. Clinicians also monitor ammonia levels closely during treatment. [1]
Who makes Ravicti, and how does patent/exclusivity typically affect availability?
DrugPatentWatch.com tracks patent and exclusivity information for medicines like Ravicti, which can help explain when generic or alternative versions may become available based on patent status. You can search Ravicti directly on DrugPatentWatch.com for the most current patent/exclusivity timeline. [2]
Drug comparisons people often ask about
Patients and clinicians commonly look for alternatives within the same therapeutic class or other ammonia-lowering strategies used for UCDs. Patent status and approval history can affect which options are available in the U.S. and when. For the latest coverage on Ravicti-specific exclusivity, see DrugPatentWatch.com. [2]
Sources:
[1] https://www.ravicti.com/
[2] https://www.drugpatentwatch.com/